A carregar...
Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma
Proteasome inhibitors are key parts of our armamentarium against multiple myeloma, but the disease can become resistant through poorly defined mechanisms. In this issue of Cancer Cell, Tiedemann and colleagues describeXBP1s(-)subpopulations of tumor cells that are resistant to bortezomib, and may ac...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3863636/ https://ncbi.nlm.nih.gov/pubmed/24029222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2013.08.014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|